Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson’s disease

por Brighina, Laura, Riva, Chiara, Bertola, Francesca, Saracchi, Enrico, Fermi, Silvia, Goldwurm, Stefano, Ferrarese, Carlo
Publicado 2013

Rotenone Upregulates Alpha-Synuclein and Myocyte Enhancer Factor 2D Independently from Lysosomal Degradation Inhibition

por Sala, Gessica, Arosio, Alessandro, Stefanoni, Giovanni, Melchionda, Laura, Riva, Chiara, Marinig, Daniele, Brighina, Laura, Ferrarese, Carlo
Publicado 2013

Association analysis of PARP1 polymorphisms with Parkinson’s disease

por Brighina, Laura, Riva, Chiara, Bertola, Francesca, Fermi, Silvia, Saracchi, Enrico, Piolti, Roberto, Goldwurm, Stefano, Pezzoli, Gianni, Ferrarese, Carlo
Publicado 2011

Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

por Theys, Kristof, Deforche, Koen, Vercauteren, Jurgen, Libin, Pieter, van de Vijver, David AMC, Albert, Jan, Åsjö, Birgitta, Balotta, Claudia, Bruckova, Marie, Camacho, Ricardo J, Clotet, Bonaventura, Coughlan, Suzie, Grossman, Zehava, Hamouda, Osamah, Horban, Andrzei, Korn, Klaus, Kostrikis, Leondios G, Kücherer, Claudia, Nielsen, Claus, Paraskevis, Dimitrios, Poljak, Mario, Puchhammer-Stockl, Elisabeth, Riva, Chiara, Ruiz, Lidia, Liitsola, Kirsi, Schmit, Jean-Claude, Schuurman, Rob, Sönnerborg, Anders, Stanekova, Danica, Stanojevic, Maja, Struck, Daniel, Van Laethem, Kristel, Wensing, Annemarie MJ, Boucher, Charles AB, Vandamme, Anne-Mieke
Publicado 2012